Swine Enzootic Pneumonia Vaccine, Inactivated

• Customization: Available
• Varieties: Vaccine
• Component: Virus
• Model NO.: Strain NJ
• Pharmacodynamic Influential Factors: Virus
• Storage Method: Prevent High or LowTemperature
• Veterinary Reg. No.: 154391144
• Usage: Administer Via Intramuscular Injection in The Neck
• Shelf Life: 18 Months
• Temperature: Store at 2-8ºC
• Withdrawal Period: 0 Day
• Package: 300 Bottles / Carton
• Transport Package: Air Way/Sea Way
• Specification: 20 ml/bottle
• Trademark: SINDER
• Origin: China
• Production Capacity: 100000L/Year
• Package Size: 61.20cm * 34.50cm * 41.00cm
• Package Gross Weight: 20.000kg

Product Description

Product Description

GENERIC NAME:
Swine Enzootic Pneumonia Vaccine, Inactivated (Strain NJ).
COMPOSITION:
This product contains Mycoplasma Hyopneumoniae (Strain NJ) ≥ 2.86 x 10⁸ CCU before Inactivated.
CHARACTERISTIC:
Water-In-Oil, White emulsion.
INDICATION(S):
The product is used for the prevention of Swine Mycoplasma Pneumonia (Swine Enzootic Pneumonia). The immunity period is 6 months.
ADMINISTRATION AND DOSAGE:
Administered via intramuscular injection. Piglets aged 7 to 56 days should be administered 1 dose (1 ml) via intramuscular injection, and an additional 1 dose (1.0 ml) after 14 days.
ADVERSE REACTIONS:
Apart from mild fever reactions observed in some pigs within 3 days after immunization, no other adverse reactions are reported. In the case of allergic reactions, prompt treatment measures should be taken.
SPECIAL WARNING IF NECESSARY:
This product is only for vaccinating healthy pig herds.

1. This product is intended for use in healthy pigs only.
2. The vaccine must not be frozen and should be protected from high temperatures or direct sunlight.
3. Once opened, the vaccine bottle should be used in a single administration.
4. The vaccine should not be used within 1 month before slaughter.
5. Standard aseptic procedures should be followed during injection.

Swine Enzootic Penumonia  Vaccine, Inactivated (Strain NJ)
(1) Tangential flow filtration technology ensures that the removal rate of small molecules, miscellaneous proteins, and other substances is over 90%.Imported high-quality equipment ensures antigen purification, bacterial purity, and low risk of side reactions.
(2) 1000L fully automatic high-density fermentation cultivation with imported adjuvants ensure that there is no significant different between different batches. Good performance for challenge test.

Shandong Sinder Technology Co., Ltd ('Sinder') founded in April 1999, has a wide range of animal health products. Sinder focus on Animal Health Products, Animal Vaccine, Antibodies, Antibiotics, Feed Additives, Chinese Herbal Product, Pet food, Elisa, and PCR test kit.

Sinder always persists in the core concept of 'The Relentless Pursuit of Increasing Customer Value. ' Based on the animal health to achieve a service provider for ecological construction of agriculture and animal husbandry. Support the efficient and sustainable development of agriculture and animal husbandry. Make food safer and rural areas better!

Sinder is a high-tech enterprise and one of the top 10 veterinary drug manufacturers in China and focusing on the animal health business. At the moment, the company has 35 GMP production lines, 1 CNAS laboratory, 3 national scientific research platforms, and 8 provincial scientific research platforms owned by Sinder.

Sinder has 4 R&D centers located in Qingdao, Zhucheng, and Beijing, China, and 1 laboratory in Silicon Valley in the United States. At present, the company has 1,535 employees including more than 200 masters or above and 18 doctors. Also, the company established extensive technical cooperation with several domestic and foreign scientific research institutes, animal health companies, and domestic veterinary medicine enterprises. Sinder has undertaken 57 national, provincial, and ministerial projects, gained 7 provincial and ministerial science and technology progress awards, presided over or participated in 23 national standards, obtained 23 new veterinary drug certificates(one 1st class new drug), and 60 authorized patents.